Todd A. Fehniger and colleagues Alice Y. Zhou, Ryan C. Fields, and George Ansstas have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.
Grant to support research on neurodegenerative disorders
Sarah Ackerman, PhD, is one of 13 early-career scientists in the U.S. to receive the 2023 Klingenstein-Simons Fellowship Award in Neuroscience. She will receive a three-year $300,000 grant to pursue high-risk, cutting-edge research.
Tony Tsai, MD, PhD, Assistant Professor of Developmental Biology, has been named a 2023 Pew Scholar in the Biomedical Sciences.
Washington University School of Medicine in St. Louis and the pharmaceutical company Eisai Co. Ltd., headquartered in Japan, have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions.
Washington University School of Medicine in St. Louis and BJC HealthCare are joining forces and partnering with CuriMeta, a new company that will accelerate lifesaving research in the fight against chronic and acute diseases that impact our communities.
Washington University in St. Louis is collaborating with the biopharmaceutical company Pfizer Inc. on research aimed at speeding the development of new drugs.